Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
25
NCT04320628
Randomized Double-Blind Controlled Clinical Trial
Phase: N/A
Role: Collaborator
Start: May 20, 2020
Completion: Mar 1, 2022